India's Zydus Life posts Q2 profit rise on steady US demand November 12, 2024 Indian generic drugmaker Lupin reported a bigger-than-expected rise in second-quarter profit on Thursday, driven by ...

Zydus said Desidustat, sold under the Oxemia trademark, is a prescription drug approved in India for patients with CKD induced anemia, and can be taken only under the advice and guidance of a ...